Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1034/j.1600-0536.2001.44020925.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The association between skin allergy testing and oral squamous cell carcinoma in oral lichen planus: a retrospective cohort study.
Arch Dermatol Res
January 2025
Department of Dermatology, Autoimmune Skin Diseases Clinic, University of Utah Spencer F. Eccles School of Medicine, 30 N Mario Capecchi Drive level 1 South, Salt Lake City, 84132, UT, USA.
There is a reported association between oral contact allergy and oral lichen planus (OLP). Likewise oral squamous cell carcinoma (oSCC) is associated with OLP. It is hypothesized that chronic inflammation may contribute to oSCC risk.
View Article and Find Full Text PDFUtilization of dupilumab in an immunocompromised patient with extensive allergic fungal rhinosinusitis unsuitable for surgical intervention: A case report.
Int J Surg Case Rep
January 2025
Department of Otolaryngology-Head & Neck, King Faisal Specialist Hospital and Research Center (KFSH&RC), Riyadh, Saudi Arabia.
Article Synopsis
- Allergic fungal rhinosinusitis (AFRS) is a type of chronic rhinosinusitis linked to a hypersensitivity to fungi, particularly affecting immunocompromised individuals.
- A 32-year-old patient with a history of Wilson's disease and a liver transplant faced severe nasal obstruction and other symptoms, leading to a diagnosis of AFRS after surgery and biopsy, but risks from carotid artery dehiscence complicated further surgical interventions.
- The patient achieved complete symptom resolution after starting dupilumab, a biologic therapy, highlighting its potential as a safe and effective treatment option for high-risk patients with AFRS.
Effects of Mepolizumab in the treatment of type 2 CRSwNP: a real-life clinical study.
Eur Arch Otorhinolaryngol
January 2025
Department of Otorhinolaryngology, Careggi University Hospital, Largo Brambilla, 3, Florence, 50134, Italy.
Purpose: Mepolizumab was recently approved for treating Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) unresponsive to standard treatment or recurring after endoscopic sinus surgery (ESS). To date, few studies have assessed Mepolizumab's efficacy in severe type-2 CRSwNP. Our study aimed to analyze sinonasal outcomes in type-2 CRSwNP patients treated with 100 mg Mepolizumab administered subcutaneously every four weeks.
View Article and Find Full Text PDFCase Report: Mixed Airborne Contact Dermatitis-Chronic Actinic Dermatitis Pattern of Parthenium Dermatitis with Response to Tofacitinib Therapy.
Am J Trop Med Hyg
June 2024
Department of Dermatology, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi, India.
Parthenium hysterophorus is the commonest cause of plant dermatitis in India. It classically causes airborne contact dermatitis (ABCD), characterized by pruritic, eczematous, and lichenified lesions involving predominantly the face and flexural areas. Over time, however, a transition to chronic actinic dermatitis (CAD) pattern, with prominent involvement of sun-exposed sites, may occur.
View Article and Find Full Text PDFAutologous Blood-Derived Products (ABDPs) for the Treatment of Chronic Wounds.
Surg Technol Int
July 2024
Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.
Autologous blood-derived therapies have emerged as a unique and promising treatment option for chronic wounds. From whole blood clots to spun-down clot constituents, these therapies are highly versatile and tend to have a lower cost profile, allow for point-of-service preparation, and inherently carry minimal to no risk of rejection or allergic reaction when compared to many alternative cellular and matrix-like products. Subsequently, a diversity of processing systems, devices, and kits have surfaced on the market for preparing autologous blood-derived products (ABDPs) and many have demonstrated preclinical and clinical efficacy in facilitating chronic wound healing.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!